Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia. (Q37571981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Kristoffer Hellstrand

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Ana I Romero

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Mats Brune

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

1217-1223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19653866%20AND%20SRC:MED&resulttype=core&format=json

Acute myeloid leukemia: epidemiology and etiology

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Epidemiology and clinical burden of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Drug therapy for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Surface NK receptors and their ligands on tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma--results from a randomised phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia--background and results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566

Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903130566